Are 2027 cars really being built with AI surveillance tech?
Quick answer
This video does not involve peptide therapy, biological compounds, or any health intervention. The subject is automotive driver monitoring technology and the regulatory and privacy questions surrounding it. No clinical claims relevant to FormBlends' peptide therapy category were made in this transcript.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @zaereacts1 actually say?
The claim is that by 2027, cars will be equipped with built-in cameras that monitor your eyes, face, and attention continuously, and that an onboard system, not you, will decide if you're fit to drive. If the system flags you as drowsy, distracted, or impaired, it can restrict or stop the car entirely. The creator frames this as surveillance dressed up as safety.
To be fair, the video doesn't fabricate this technology. Driver monitoring systems (DMS) are real, they're already here, and the 2027 timeline is not science fiction. What the video does, though, is skip over the nuance almost entirely in favor of a surveillance narrative that's only partly supported by how these systems actually work.
Does the science back this up?
Mostly, yes, but not in the dystopian terms the video implies. Driver monitoring technology is well-documented and the regulatory push behind it is real. The European Union's General Safety Regulation (GSR2) mandated driver drowsiness and attention warning systems in all new vehicles sold in the EU starting July 2024. In the U.S., the NHTSA has been evaluating similar requirements.
Research behind DMS is legitimate. Klauer et al. (2006, NHTSA) found drowsy and distracted driving contributed to 78% of crashes studied in naturalistic driving data. More recent work, including Tran et al. (2022, Sensors), has validated infrared-based eye-tracking as a reliable drowsiness indicator in real driving conditions. The technology works. The policy questions around it, however, are genuinely unsettled, and the creator isn't wrong to raise them.
What did they get wrong (or right)?
They got the core technology right. Cameras monitoring eyes and faces are either standard or optional equipment in many 2024-2025 vehicles already, including Tesla, Subaru, and GM models. Volvo's Driver Alert system has been in production for years. The "2027" framing makes it sound like a sudden rollout when it's already a gradual one.
What they got wrong is the claim that the system "can stop the car altogether." Current production DMS systems do not do this autonomously. They alert the driver, and in advanced systems like semi-autonomous setups, they may require the driver to take control before disengaging autopilot. A full autonomous stop of a vehicle is not standard DMS functionality. That's a meaningful overstatement.
The creator also doesn't address who actually stores this data or whether any current system transmits biometric data off the vehicle in real time. That's the real surveillance question, and it goes completely unasked.
What should you actually know?
Driver monitoring is not a 2027 secret. Euro NCAP began scoring DMS in its 2022 safety ratings, meaning automakers building five-star cars had commercial incentive to install these systems years ago. If you've driven a new car recently, you may already have one.
The legitimate privacy concern isn't whether the camera exists, it's what happens to the data. Some automakers retain driver behavior data. Some share it with insurers. A 2023 Mozilla Foundation report, "It's Official: Cars Are the Worst Product Category We Have Ever Reviewed for Privacy," found that 84% of car brands studied share or sell personal data, including location and behavioral data. That's the story worth telling. The creator touched the surface of a real issue but wrapped it in vague "they" framing instead of naming the actual data practices that deserve scrutiny.
- DMS technology is already in millions of vehicles sold globally before 2027.
- EU law requires drowsiness warning systems in all new cars sold after July 2024.
- No current standard DMS system fully stops a vehicle based solely on driver state without driver input.
- The real privacy risk is data retention and third-party sharing, not a camera watching your eyes.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 5 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Are 2027 cars really being built with AI surveillance tech?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Are 2027 cars really being built with AI surveillance tech? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
This video does not involve peptide therapy, biological compounds, or any health intervention.
FormBlends verdict
This video does not involve peptide therapy, biological compounds, or any health intervention. The subject is automotive driver monitoring technology and the regulatory and privacy questions surrounding it. No clinical claims relevant to FormBlends' peptide therapy category were made in this transcript.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- This video does not involve peptide therapy, biological compounds, or any health intervention. The subject is automotive driver monitoring technology and the regulatory and privacy questions surrounding it. No clinical claims relevant to FormBlends' peptide therapy category were made in this transcript.
- Euro NCAP began scoring driver monitoring systems in 2022 safety ratings, giving automakers years of commercial incentive to install these cameras before any 2027 mandate.
- EU General Safety Regulation 2 required drowsiness and attention warning systems in all new cars sold after July 7, 2024, making '2027' a late estimate, not a coming shock.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Euro NCAP began scoring driver monitoring systems in 2022 safety ratings, giving automakers years of commercial incentive to install these cameras before any 2027 mandate.
- EU General Safety Regulation 2 required drowsiness and attention warning systems in all new cars sold after July 7, 2024, making '2027' a late estimate, not a coming shock.
- Klauer et al. (2006, NHTSA) documented drowsy and distracted driving in 78% of crash events in naturalistic data, which is the actual evidence base for DMS safety claims.
- No current standard production DMS system autonomously stops a vehicle based on driver state alone. The 'stops the car altogether' claim overstates what these systems currently do.
- Mozilla Foundation's 2023 car privacy review found 84% of studied automakers share or sell driver data, including behavioral data, which is the real surveillance issue the video skips.
- Tran et al. (2022, Sensors) validated infrared eye-tracking as a reliable drowsiness detection method in real driving conditions, confirming the underlying technology is scientifically sound.
- The unanswered question is not whether the camera watches you, it is whether that data is sold to insurers, retained by manufacturers, or shared with third parties without clear consent.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
zaereacts1 · TikTok creator
9.9K views on this video
They’re Putting THIS in Every New Car #2027 #ai #car #surveillance #technews
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by zaereacts1, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.